IWS 66 - Impactful clinical research: Comparison of supplemental screening technologies — interim results from the BRAID randomized trial including patient experience insights

Join us for an insightful session with Dr. Iris Allajbeu as they present interim findings from the BRAID randomized controlled trial, one of the most comprehensive studies comparing supplemental breast screening technologies in women with dense breast tissue. The session will examine the performance of abbreviated MRI, automated breast ultrasound (ABUS) and contrast-enhanced mammography (CEM) in terms of cancer detection, recall and biopsy rates, with a forward-looking view into findings from the second screening round. In addition to clinical outcomes, the discussion will include valuable insights from the patient experience subset, offering a well-rounded perspective on both clinical effectiveness and patient-centric care. Don’t miss this opportunity to explore the evolving landscape of breast imaging through the lens of impactful clinical research.